I Q D

WIPO WIPO 2010

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke I Q D wurde als Bildmarke am 21.12.2010 bei der Weltorganisation für geistiges Eigentum angemeldet.

Logodesign (Wiener Klassifikation)

#Teile des menschlichen Körpers, Skelette, Schädel #Briefe, die eine besondere Form des Schreibens darstellen #Abdrücke von Händen oder Fingern #Buchstaben, die mit einem figurativen Element verbunden sind

Markendetails Letztes Update: 22. Oktober 2021

Markenform Bildmarke
Aktenzeichen 1076309
Registernummer 009228412
Länder Australien Schweiz China Japan Nordkorea Südkorea Norwegen Russland Singapur Türkei
Basismarke EU Nr. 009228412, 06. Dezember 2010
Anmeldedatum 21. Dezember 2010
Ablaufdatum 21. Dezember 2020

Markeninhaber

P.O. Box 10101
220 10 Lund
SE

Markenvertreter

7, avenue Lionel Terray F-69330 Meyzieu cedex FR

Waren und Dienstleistungen

09 Data processing equipment and computers for medical purposes for use in operating computer operated medical apparatus, for use in medical database management, for monitoring and controlling of one or more dialysis monitors, water treatment equipment like reverse osmosis (RO) machines, central solution preparation machines, or for operating blood component collection systems, especially for use in measuring dialysis output of dialysis monitors, for generating dialysis patient reports, and for managing dialysis facilities, for managing dialysis establishments, for measuring and predicting the efficiency of blood component collection, for producing reports on blood component donors, for managing blood component collection establishments and blood banks, for managing illnesses; scientific devices for detection, monitoring, display of dialysis treatment parameters, namely detection, monitoring and display of clearance, dialysance, and dialysis dose
10 Medical apparatus and instrument for extracorporeal blood treatment; medical apparatus and instruments for the treatment of renal insufficiency; apparatus for hemodialysis, and/or hemofiltration, and/or hemodiafiltration; components and devices for use in the above-mentioned treatments and therapies, namely, filters for dialysis fluids, dialyzers, dialysis monitors, blood tubes, blood pumps, cannulas, catheters, needles for medical use, anticoagulant pumps, tube sets for priming, drip chambers, expansion chambers, pressure sensors, flow meters, temperature meters, conductivity meters, ion strength meters, heat exchangers, devices for heating and cooling, connectors, apparatus for measuring of urea and other substances in blood, apparatus and means for preparation of dialysis fluid and other medical fluids, for example replacement fluids, disinfection solutions, cleansing solutions, decalcifying solutions, water treatment equipment intended for medical use, apparatus for extracorporeal blood handling related to bone marrow processing, cell processing, apheresis, blood separation and filtering, therapeutic blood treatments, and disposable therefor; bags and cartridges for concentrates in solid or liquid form, bags and cartridges for solutions intended for medical use, for example for peritoneal dialysis fluid; membranes intended for medical use, including membranes for use in filters for dialysis, hemofiltration and hemodiafiltration
35 Advertising; business management; business and management services offered to hospitals and clinics
41 Educational services; individual and group educational instruction; educational and training courses for young people and adults, all said services related to the medical field, in particular extracorporeal blood treatment, namely, hemodialysis, hemofiltration, hemodiafiltration; training groups and individuals on machines and equipments used for extracorporeal blood treatment and treatment of renal insufficiency; arranging and conducting of conferences, seminars, symposiums, workshops, congresses on the subjects of extracorporeal blood treatment and treatment of renal insufficiency
42 Scientific, research and development services for medical purposes, namely, in relation with extracorporeal blood treatment and treatment of renal insufficiency; creation and development of computer software in the domain of extracorporeal blood treatment and treatment of renal insufficiency
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
21. Oktober 2021 2021/42 Gaz Löschung
25. Januar 2013 2013/5 Gaz TR Ablehnung
01. November 2012 2012/44 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
09. Juli 2012 2012/28 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
30. Mai 2012 2012/23 Gaz CH Ablehnung
28. März 2012 2012/14 Gaz RU Ablehnung
26. März 2012 2012/15 Gaz CN Ablehnung
13. Januar 2012 2012/3 Gaz NO Ablehnung
01. Dezember 2011 2011/48 Gaz JP Ablehnung
30. November 2011 2011/48 Gaz SG Ablehnung
21. November 2011 2011/47 Gaz AU Ablehnung
07. November 2011 2011/45 Gaz KR Ablehnung
21. Dezember 2010 2011/20 Gaz EM Eintragung

ID: 141076309